Cogent Biosciences Unveils Positive Data from SUMMIT Trial of Bezuclastinib in Nonadvanced Systemic Mastocytosis Patients.
Positive 1b Data For Mastocytosis Therapy Announced By Major Biotech Company
Positive 1b Data For Mastocytosis Therapy…
Positive 1b Data For Mastocytosis Therapy Announced By Major Biotech Company
Cogent Biosciences Unveils Positive Data from SUMMIT Trial of Bezuclastinib in Nonadvanced Systemic Mastocytosis Patients.